A National Research Priority Program of  
the

Logo der Deutschen Forschungsgesellschaft

2010

Braunewell KH, Paul B, Altarche-Xifro W, Noack C, Lange K and Hofmann A (2010) Interactions of Visinin-like Proteins with Phospho-inositides. Aust. J. Chem. 63:350–356.

Breitling LP, Arndt V, Drath C, Rothenbacher D, Brenner H (2010) Smoking and γ-glutamyltransferase: opposite interactions with alcohol consumption and body mass index. PLoS One. 5(9). pii: e13116.

Breitling LP, Müller H, Raum E, Rothenbacher D, Brenner H (2010) Low-to-moderate alcohol consumption and smoking cessation rates: retroperspective analysis of 4576 elderly ever-smokers. Drug Alcohol Depend 2010 108:122-129.

Breitling LP, Twardella D, Hoffmann MM, Witt SH, Treutlein J, Brenner H (2010) Prospective association of dopamine-related polymorphisms with smoking cessation in general care. Pharmacogenomics 11(4):527-36.

Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann US (2010) Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol. (2):247-55.

Bühler M, Vollstädt-Klein S, Kobiella A, Budde H, Reed LJ, Braus DF, Büchel C, Smolka MN (2010) Nicotine dependence is characterized by disordered reward processing in a network driving motivation. Biol Psychiatry 67(8):745-52.

Drews E, Zimmer A (2010) Modulation of alcohol and nicotine responses through the endogenous opioid system. Prog Neurobiol. 90(1):1-15.

Hurlemann R, Patin A, Onur OA, Cohen MX, Baumgartner T, Metzler S, Dziobek I, Gallinat J, Wagner M, Maier W, Kendrick KM (2010) Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. The Journal of Neuroscience 30:4999-5007.

Jähne A, Cohrs S, Rodenbeck A, Andreas S, Loessl B, Feige B, Kloepfer C, Hornyak M, Riemann D (2010) Nicotine. Influence on sleep and its relevance for psychiatry and psychotherapy. Nervenarzt 81(7):844-59.

Kühn S, Schubert F, Gallinat J (2010) Reduced Thickness of Medial Orbitofrontal Cortex in Smokers. Biol Psychiatry, 68:1061-19065.

Lenz B, Klafi HW, Hillemacher T, Killisch N, Schaller G, Frieling H, Clepce M, Gossler A, Thouerauf N, Winterer G, Kornhuber J, Bleich S (2010): Smoking behavior is associated with expression and phosphorylation of CREB in human buffy coat. Int J Neuropsychopharmacol. 13(2):207-215.

Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, Barroso I, Khaw KT, Grundy S, Barter P, Mahley R, Kesaniemi A, McPherson R, Vincent JB, Strauss J, Kennedy JL, Farmer A, McGuffin P, Day R, Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M, Brueckl T, Horstmann S, Wichmann HE, Rawal R, Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J, Campbell S, Kooner J, Chambers JC, Burnett MS, Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H, Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W, Hakonarson HH, Rader DJ, Franke A, Wittig M, Schäfer A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P, Schlessinger D, St Clair D, Rujescu D, Abecasis GR, Grabe HJ, Teumer A, Völzke H, Petersmann A, John U, Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ, Thompson JR, Balmforth AJ, Hall AS, Samani NJ, Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi J, Caulfield M, Munroe PB, Farrall M, Dominiczak A, Worthington J, Thomson W, Eyre S, Barton A; Wellcome Trust Case Control Consortium, Mooser V, Francks C, Marchini J (2010). Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genet 42:436-40.

Mihov Y, Mayer S, Musshoff F, Maier W, Kendrick KM, Hurlemann R (2010) Facilitation of learning by social-emotion feedback is beta-noradrenergic-dependent. Neuropsychologia 48 (10): 3168-7.

Mobascher A, Brinkmeyer J, Warbrick T, Wels C, Wagner M, Gründer G, Spreckelmeyer KN, Wienker T, Diaz Lacava A, Dahmen N, Böttcher M, Thuerauf N, Clepce M, Kiefer F, De Millas W, Gallinat J, Winterer G (2010) The P300 event-related potential and smoking - A population-based case-control study. Int J Psychophysiol. 77(2):166-75.

Mobascher A, Rujescu D, Mittelstrass K, Giegling I, Lamina C, Nitz B, Brenner H, Fehr C, Breitling LP, Gallinat J, Rothenbacher D, Raum E, Müller H, Ruppert A, Hartmann AM, Möller HJ, Gal A, Gieger Ch, Wichmann HE, Illig T, Dahmen N, Winterer G (2010) Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. Am J Med Genet B Neuropsychiatr Genet. 153B(2):684-90.

Musso F, Brinkmeyer J, Mobascher A, Warbrick T, Winterer G (2010). Spontaneous brain activity and EEG microstates. A novel EEG/fMRI analysis approach to explore resting-state networks. NeuroImage 52(4) 1149-1161.

Onur OA, Schlaepfer TE, Kukolja J, Bauer A, Jeung H, Patin A, Otte DM, Shah NJ, Maier W, Kendrick KM, Fink GR, Hurlemann R (2010) The NMDA receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans. Biological Psychiatry 67 (12): 1205-1211.

Petrovsky N, Quednow BB, Ettinger U, Schmechtig A, Mössner R, Collier DA, Kühn KU, Maier W, Wagner M, Kumari V (2010) Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology 35(7):1429-39.

Steinlein OK, Bertrand D (2010) Nicotinic receptor channelopathies and epilepsy. Pflugers Arch 460(2):495-503.

Thirugnanasambadam N, Grundez J, Adam K, Drees A, Skwirba AC, Lang N, Paulus W, Nitsche MA (2010) Nicotinic impact on focal and non-focal neuroplasticity induced by non-invasive brain stimulation in non-smoking humans. Neuropsychopharmacology 36: 879-886.

 Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR; ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K. (2010) Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genet 42:448-53.

Vollstädt-Klein S, Kobiella A, Bühler M, Graf C, Fehr C, Mann K, Smolka MN (2010) Severity of dependence modulates smokers' neuronal cue reactivity and cigarette craving elicited by tobacco advertisement. Addict Biolgy 16(1): 166-175.

von der Goltz C, Koopmann A, Dinter C, Richter A, Rockenbach C, Grosshans M, Nakovics H, Wiedemann K, Mann K, Winterer G, Kiefer F (2010) Orexin and leptin are associated with nicotine craving: a link between smoking, appetite and reward. Psychoneuroendocrinology 35(4):570-7.

Winterer, G (2010): Risk gene variants for nicotine dependence: a success story in neuropsychiatric genetics with possible applications to drug development. Pharmacogenomics 11(10):1353-7.

Winterer, G (2010): Why do patients with schizophrenia smoke? Curr Opin Psychiatry 23(2):119-119.

Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, Brenner H, Breitling LP, Nitz B, Raum E, Müller H, Gallinat J, Gal A, Heim K, Prokisch H, Meitinger T, Hartmann AM, Möller HJ, Gieger C, Wichmann HE, Illig T, Dahmen N, Rujescu D (2010) Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet. 153B (8):1448-1458.